L3VLUP
ProSign in

BCRX · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

BCRXAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • BCRX
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterBCRXAMGN
Q3 20202 holders, $4.8m16 holders, $16.3bn
Q4 20203 holders, $33m19 holders, $14.0bn
Q1 20211 holders, $31m16 holders, $14.5bn
Q2 20213 holders, $88m23 holders, $13.8bn
Q3 20216 holders, $119m24 holders, $11.6bn
Q4 20214 holders, $79m21 holders, $10.4bn
Q1 20225 holders, $83m23 holders, $9.9bn
Q2 20224 holders, $60m28 holders, $9.7bn
Q3 20227 holders, $85m21 holders, $7.9bn
Q4 20228 holders, $111m24 holders, $9.3bn
Q1 20236 holders, $59m22 holders, $8.4bn
Q2 20234 holders, $53m26 holders, $7.4bn
Q3 20234 holders, $44m26 holders, $8.7bn
Q4 20232 holders, $15m24 holders, $8.4bn
Q1 20243 holders, $16m25 holders, $6.7bn
Q2 20243 holders, $30m20 holders, $8.0bn
Q3 20243 holders, $34m21 holders, $8.8bn
Q4 20242 holders, $23m20 holders, $8.2bn
Q1 20254 holders, $50m25 holders, $12.0bn
Q2 20257 holders, $170m20 holders, $10.2bn
Q3 20255 holders, $74m17 holders, $10.4bn
Q4 20256 holders, $138m19 holders, $18.0bn
Q1 20266 holders, $170m15 holders, $21.4bn
Q2 20267 holders, $187m23 holders, $24.9bn
BCRX

Biocryst Pharmaceuticals Inc

Holders
7
Reported value
$187m
Buyers
22
Sellers
12

Breadth +10 among 91 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
23
Reported value
$24.9bn
Buyers
19
Sellers
13

Breadth +6 among 91 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q2 2026

Among the 26 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only BCRX (3)

ExodusPoint Capital Management LP, Moore Capital Management LP, Winton Group Ltd

Only AMGN (19)

AllianceBernstein LP, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Marshall Wace LLP, Neuberger Berman Group LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Walleye Capital LLC, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →